ARTICLE | Company News
Intrinsic Bioprobes sales and marketing update
April 25, 2011 7:00 AM UTC
Intrinsic Bioprobes launched spectrometry-based protein assays for beta-2 microglobulin (B2M), cystatin C (CST3) and retinol binding protein 4 plasma (RBP4) in the U.S. for diagnosing kidney diseas...